Incidence of gastrointestinal bleeding in patients with cardiovascular disease: Buffered aspirin versus enteric-coated aspirin

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 7-8, 2011, Pages 803-809

  Hirata, Yoshikazu ^a   Kataoka, Hiromi ^a   Shimura, Takaya ^a   Mizushima, Takashi ^a   Mizoshita, Tsutomu ^a   Tanida, Satoshi ^a   Kamiya, Takeshi ^a   Joh, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Buffered aspirin; Enteric coated aspirin; Gastrointestinal bleeding; Low dose aspirin

Indexed keywords

ACETYLSALICYLIC ACID; GASTROINTESTINAL AGENT; HEMOGLOBIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEMOGLOBIN BLOOD LEVEL; HUMAN; LARGE INTESTINE HEMORRHAGE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE HEMORRHAGE; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING;

AGED; AGED, 80 AND OVER; ASPIRIN; BUFFERS; CARDIOVASCULAR DISEASES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TABLETS, ENTERIC-COATED;

EID: 79960202077     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.568522     Document Type: Article

References (25)

1. Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101(10): 1206-18.
2. Weiss HJ, Aledort LM. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet 1967;2(7514): 495-7.
3. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86.
4. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310(6983):827- 30.
5. Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006; 333(7571):726.
6. Laine L. Review article: gastrointestinal bleeding with lowdose aspirin - what's the risk? Aliment Pharmacol Ther 2006; 24(6):897-908. (Pubitemid 44326371)
7. Cryer B, Feldman M. Effects of very low dose daily, longterm aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999;117(1):17-25. (Pubitemid 29297615)
8. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997;112(3):1000-16. (Pubitemid 27113828)
9. Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008; 6(11):1279-82.
10. Ng FH, Wong SY, Lam KF, Chang CM, Lau YK, Chu WM, et al. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome. Am J Gastroenterol 2008;103(4): 865-71.
11. Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, et al. Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009;79(1):44-51.
12. Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, et al. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 2010;45(3): 292-8.
13. Thrombosis prevention trial: randomised trial of lowintensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998;351 (9098):233-41.
14. Banoob DW, McCloskey WW, Webster W. Risk of gastric injury with enteric- versus nonenteric-coated aspirin. Ann Pharmacother 2002;36(1):163-6. (Pubitemid 34052959)
15. Lanza FL, Royer GL Jr, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl JMed 1980; 303(3):136-8. (Pubitemid 10076606)
16. Petroski D. Endoscopic comparison of three aspirin preparations and placebo. Clin Ther 1993;15(2):314-20. (Pubitemid 23168494)
17. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major uppergastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996;348(9039):1413-16. (Pubitemid 26395236)
18. Sorensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000;95(9):2218-24.
19. Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002;55(7):775-9.
20. Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010; 152(1):1-9.
21. Hayashi Y, Yamamoto H, Kita H, Sunada K, Sato H, Yano T, et al. Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol 2005;11(31):4861-4. (Pubitemid 41223298)
22. Yen HH, Chen YY, Soon MS. The role of double-balloon endoscopy in NSAID enteropathy. Gastrointest Endosc 2006;64(6):1035-6.
23. Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by doubleballoon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008;43(4):490-6. (Pubitemid 351450993)
24. Slattery J, Warlow CP, Shorrock CJ, Langman MJ. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995;37(4):509-11.
25. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348(9038):1329-39.